Adverse Reaction to Drug Clinical Trial
Official title:
Post-market Safety Reassessment of Ulinastatin for Injection
1. Investigate the application of ulinastatin(UTI) in real practice clinic.(eg:population
character, usage and dosage, course of treatment,etc )
2. Analysis the incidence of adverse drug reactions /adverse events of ulinastatin, collect
the main clinical manifestations, treatment, outcome, influence factors; provide
evidence for improving the recommended medication plan of ulinastatin.
3. Evaluate the safety of ulinastatin , obtain scientific conclusion , and provide evidence
for appropriate medication to administration department of health authority.
In order to find out the application of ulinastatin in real practice clinic , identify the high risk group for adverse event/adverse drug reaction and calculate the adverse event/adverse drug reaction incidence rate, a large sample size clinical trial has been designed. This trial is an observational study. The investigators would screen several hospitals from different provinces and prospectively collect the main clinical manifestations,treatment, outcome, influence factors about patients using ulinastatin either in general clinical departments or in ICU. This study would be expected to provide evidence for appropriate medication to administration department of health authority. ;
Status | Clinical Trial | Phase | |
---|---|---|---|
Withdrawn |
NCT01430702 -
Feasibility of Using a Telemedicine Medication Delivery Unit for Older Adults
|
N/A | |
Active, not recruiting |
NCT01237275 -
Development of A Technique to Predict Antidepressant Responsiveness in Depressive Patients
|
N/A | |
Terminated |
NCT02296840 -
Post-operative Pain Control After Pediatric Adenotonsillectomy
|
Phase 4 | |
Terminated |
NCT01600677 -
Determining the Impact of a Medication Delivery Unit on Medication Adherence of Adults With Common Cardiac Conditions
|
N/A | |
Recruiting |
NCT02353455 -
Cells of Monocytic Origin as Surrogate Markers for Individual Drug Effects and Hepatotoxicity
|
||
Completed |
NCT02012712 -
Personal Health Records and Elder Medication Use Quality
|
N/A | |
Completed |
NCT02609919 -
Assessment of Immediate Adverse Reactions From Dotarem in Children Under 2 Years of Age
|
||
Completed |
NCT06124417 -
Efficacy and Safety of Sertraline in the Treatment of Maintenance Hemodialysis Patients With Depression
|
Phase 4 | |
Recruiting |
NCT00817375 -
Pharmacogenomic Study to Predict Antidepressant Responsiveness in Depressed Patients
|
N/A | |
Active, not recruiting |
NCT00935246 -
Development of Escitalopram Genomic Device by Using Candidate Gene Approach and Genome-Wide Scanning
|
N/A | |
Completed |
NCT04226443 -
The Use of Midazolam and Remifentanil During Dialysis Access Procedures
|
N/A | |
Completed |
NCT01621373 -
Exploratory Propofol Dose Finding Study In Neonates
|
Phase 2 | |
Completed |
NCT02447679 -
Oral Thalidomide and Tegafur-uracil to Decrease Hepatocellular Carcinoma Recurrence
|
Phase 2 | |
Recruiting |
NCT05645302 -
Intensive Monitoring Scheme of Lidocaine Cataplasms
|
||
Enrolling by invitation |
NCT01830257 -
Explore Active Surveillance Mode of the Community's Adverse Event Following Immunization(AEFI)
|
Phase 4 | |
Recruiting |
NCT01354197 -
The Thai Surgical Intensive Care Study (Thai-SICU Study)
|
N/A | |
Recruiting |
NCT04655794 -
Clinical Analysis of Safety in Latent Tuberculosis Infection Prophylaxis Treatment
|